183 related articles for article (PubMed ID: 20573757)
1. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
Lynch JJ; Regan CP; Edvinsson L; Hargreaves RJ; Kane SA
J Cardiovasc Pharmacol; 2010 May; 55(5):518-21. PubMed ID: 20164785
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
4. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
5. Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries.
Edvinsson L; Ahnstedt H; Larsen R; Sheykhzade M
Acta Physiol (Oxf); 2014 Apr; 210(4):811-22. PubMed ID: 24330354
[TBL] [Abstract][Full Text] [Related]
6. Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).
Paone DV; Shaw AW; Nguyen DN; Burgey CS; Deng JZ; Kane SA; Koblan KS; Salvatore CA; Mosser SD; Johnston VK; Wong BK; Miller-Stein CM; Hershey JC; Graham SL; Vacca JP; Williams TM
J Med Chem; 2007 Nov; 50(23):5564-7. PubMed ID: 17929795
[TBL] [Abstract][Full Text] [Related]
7. Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.
Edvinsson L; Chan KY; Eftekhari S; Nilsson E; de Vries R; Säveland H; Dirven CM; Danser AH; MaassenVanDenBrink A
Cephalalgia; 2010 Oct; 30(10):1233-40. PubMed ID: 20855369
[TBL] [Abstract][Full Text] [Related]
8. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
Waugh DJ; Bockman CS; Smith DD; Abel PW
J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of the (3R,6S)-3-amino-6-(2,3-difluorophenyl)azepan-2-one of telcagepant (MK-0974), a calcitonin gene-related peptide receptor antagonist for the treatment of migraine headache.
Burgey CS; Paone DV; Shaw AW; Deng JZ; Nguyen DN; Potteiger CM; Graham SL; Vacca JP; Williams TM
Org Lett; 2008 Aug; 10(15):3235-8. PubMed ID: 18590336
[TBL] [Abstract][Full Text] [Related]
10. Characterization of calcitonin gene-related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats.
Sheykhzade M; Nyborg NC
Br J Pharmacol; 1998 Apr; 123(7):1464-70. PubMed ID: 9579744
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca
Erdling A; Sheykhzade M; Edvinsson L
J Headache Pain; 2017 Dec; 18(1):61. PubMed ID: 28560541
[TBL] [Abstract][Full Text] [Related]
12. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
13. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
Yoshimoto R; Mitsui-Saito M; Ozaki H; Karaki H
Br J Pharmacol; 1998 Apr; 123(8):1645-54. PubMed ID: 9605572
[TBL] [Abstract][Full Text] [Related]
14. Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
Moore EL; Burgey CS; Paone DV; Shaw AW; Tang YS; Kane SA; Salvatore CA
Eur J Pharmacol; 2009 Jan; 602(2-3):250-4. PubMed ID: 19084002
[TBL] [Abstract][Full Text] [Related]
15. Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide.
Gazzieri D; Trevisani M; Tarantini F; Bechi P; Masotti G; Gensini GF; Castellani S; Marchionni N; Geppetti P; Harrison S
Cardiovasc Res; 2006 Jun; 70(3):589-99. PubMed ID: 16579978
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.
Hostetler ED; Joshi AD; Sanabria-Bohórquez S; Fan H; Zeng Z; Purcell M; Gantert L; Riffel K; Williams M; O'Malley S; Miller P; Selnick HG; Gallicchio SN; Bell IM; Salvatore CA; Kane SA; Li CC; Hargreaves RJ; de Groot T; Bormans G; Van Hecken A; Derdelinckx I; de Hoon J; Reynders T; Declercq R; De Lepeleire I; Kennedy WP; Blanchard R; Marcantonio EE; Sur C; Cook JJ; Van Laere K; Evelhoch JL
J Pharmacol Exp Ther; 2013 Nov; 347(2):478-86. PubMed ID: 23975906
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in calcitonin gene-related Peptide-induced relaxation in pregnant rat uterine artery.
Gangula PR; Thota C; Wimalawansa SJ; Bukoski RD; Yallampalli C
Biol Reprod; 2003 Nov; 69(5):1635-41. PubMed ID: 12855600
[TBL] [Abstract][Full Text] [Related]
19. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
Connor KM; Aurora SK; Loeys T; Ashina M; Jones C; Giezek H; Massaad R; Williams-Diaz A; Lines C; Ho TW
Headache; 2011 Jan; 51(1):73-84. PubMed ID: 21070230
[TBL] [Abstract][Full Text] [Related]
20. Endothelin receptor subtypes and their functional relevance in human small coronary arteries.
Pierre LN; Davenport AP
Br J Pharmacol; 1998 Jun; 124(3):499-506. PubMed ID: 9647474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
